Author(s): Stella Pelengaris (Editor), Michael Khan
Publisher: Wiley–Blackwell
Publication Date: 27 Mar. 2006
Language: English
Print length: 544 pages
ISBN-10: 1405118148
ISBN-13: 9781405118149
Book Description
This comprehensive text provides a detailed overview of the molecular mechanisms underpinning the development of cancer and its treatment. Written by an international panel of researchers, specialists and practitioners in the field, the text discusses all aspects of cancer biology from the causes, development and diagnosis through to the treatment of cancer. Written by an international panel of researchers, specialists and practitioners in the field Covers both traditional areas of study and areas of controversy and emerging importance, highlighting future directions for research Features up–to–date coverage of recent studies and discoveries, as well as a solid grounding in the key concepts in the field Each chapter includes key points, chapter summaries, text boxes, and topical references for added comprehension and review Supported by a dedicated website at www.blackwellpublishing.com/pelengaris An excellent text for upper–level courses in the biology of cancer, for medical students and qualified practitioners preparing for higher exams, and for researchers and teachers in the field
Editorial Reviews
Review
“The explosion of information on the molecular biology of cancer, and its widespread and immediate availability via the internet, provides major challenges for those engaged in cancer treatment and research. A single up–to–date reference textbook on this topic is needed more than ever. This book will go a long way towards meeting this need, providing a valuable resource for a range of individuals and departments.” Stan Kaye, Royal Marsden Hospital, London “Pelengaris, Khan, and the contributing authors are to be applauded. The Molecular Biology of Cancer is a comprehensive and readable presentation of the many faces of cancer from molecular mechanisms to clinical therapies and diagnostics. This book will be welcomed by neophyte students, established scientists in other fields, and curious physicians.” Dean Felsher, Stanford University “This book deserves great praise for the readable presentation of this complex field.” Molecular Cancer, November 2007
From the Back Cover
This comprehensive text provides a detailed overview of the molecular mechanisms underpinning the development of cancer and its treatment. Written by an international panel of researchers, specialists and practitioners in the field, the text discusses all aspects of cancer biology from the causes, development and diagnosis through to the treatment of cancer. The text offers in–depth coverage of traditional areas of study, while also discussing areas of controversy and emerging importance and highlighting future directions for research. Common cancers such as lung, breast, colon and skin cancer are used to illustrate key concepts and fundamental biological processes throughout the text. In addition, each chapter includes key points, chapter summaries, text boxes, and topical references for added comprehension and review. Offering up–to–date coverage of recent studies and discoveries, as well as a solid grounding in the key concepts in the field, this book will be an excellent text for upper–level courses in the biology of cancer, for medical students and qualified practitioners preparing for higher exams, and for researchers and teachers in the field.
About the Author
Stella Pelengaris PhD is a Senior Research Fellow in Molecular Medicine in the Department of Biological Sciences at the University of Warwick and Warwick Medical School. While working as a PDRA at the Imperial Cancer Research Fund, she established a series of unique model systems for studying the role of c–Myc and apoptosis in cancer initiation and reversal. Since 1999 she and Mike Khan have jointly run the cancer biology research group at the University of Warwick where, in collaboration with Gerard Evan, they have confirmed the inherent tumor–suppressor activity of c–Myc (apoptosis) as a major barrier to oncogenic deregulation of c–Myc. The group is currently researching the role of c–Myc in both oncogenesis and in the apoptosis of beta cells in diabetes. Mike Khan PhD FRCP is a Consultant Endocrinologist and Physician at the University Hospitals of Coventry and Warwickshire and Head of Molecular Medicine at the University of Warwick and Warwick Medical School. He was elected as a Fellow of the Royal College of Physicians in 2002 and as a Member of the Association of Physicians in 2004. His main research interests have been in the regulation of tissue growth and plasticity during development and in adult tissue homeostasis. Currently, he is collaborating with mathematicians and others in a systems biology approach to define key functional gene and protein networks involved in regulating cell fate. Dr Khan and Dr Pelengaris jointly run various postgraduate training courses at masters level and beyond in cancer biology and in lipid metabolism/diabetes. They also are coauthors of the textbook Lipids and Diabetes (2002).
Wow! eBook
